MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
IMVT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Immunovant (IMVT) Ownership - Who owns Immunovant?

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
320 West 37th Street
Phone
+1 917 580-3099
Employees
362
Web
https://www.immunovant.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
7.91B
P/E Ratio
N/A
Total Cash
902.11M
Projected Growth
N/A
Total Debt
72K
Revenue
N/A
Risk (Beta)
0.38
Dividend Yield
N/A
Total Cash/Share
4.39
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
IMVT
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for IMVT
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases.

Industry Biotechnology

Profile
Details
Industry
N/A
Address
320 West 37th Street
Phone
+1 917 580-3099
Employees
362
Web
https://www.immunovant.com